GERM
ETFMG Treatments, Testing and Ad
GERM
19,16
0,01 Bil. AUM
0,7% Expense Ratio
18,36 NAV
ETFMG Treatments, Testing and Ad Profile
About ETFMG Treatments, Testing and Ad
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
- Company
- Holdings
- 62
- CUSIP
ETFMG Treatments, Testing and Ad Sectors
| Industry | Percentage |
|---|---|
| Healthcare | 99,54% |
| Other | 0,46% |